With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test

 

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
      Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford.